TREATMENT OPTIMISATION OF MULTIDRUG-RESISTANT TUBERCULOSIS IN UZBEKISTAN
Keywords:
Treatment, optimization, multidrug-resistant tuberculosis, Uzbekistan, tuberculosis control, drug resistance, treatment outcomes, healthcare system, Directly Observed Treatment, Short-course (DOTS)Abstract
In this article, we aim to explore the current landscape of MDR-TB treatment optimization in Uzbekistan. We will delve into the challenges faced by healthcare systems in providing adequate care to MDR-TB patients and highlight potential strategies to overcome these obstacles. By reviewing the existing literature, examining relevant policies, and analyzing the experiences of healthcare providers and patients, we will strive to provide a comprehensive overview of the efforts made and the work yet to be done in the battle against MDR-TB in Uzbekistan.
References
Kuhlin, J. (2023). Treatment optimisation of multidrug-resistant tuberculosis.
Mamajanov, I. (2023). CLINICAL STRUCTURE OF TUBERCULOSIS IN THE ELDERLY. International Bulletin of Medical Sciences and Clinical Research, 3(5), 91-93.
Solidjonov, D. (2021). ISSUES OF ECONOMIC DEVELOPMENT AND INTERNATIONAL INTEGRATION IN THE NEW UZBEKISTAN. Scienceweb academic papers collection.
Abdullaevna, R. S., & Rakhmanovich, M. B. (2023). Immunological Features of Pulmonary Tuberculosis in Patients with Drug Resistance. Scholastic: Journal of Natural and Medical Education, 2(4), 40-57.
Moe, S., Rekart, M. L., Hernandez, D., Sholpan, A., Ismailov, A., Oluya, M., ... & Sinha, A. (2023). Primary bedaquiline resistance in Karakalpakstan, Uzbekistan. The International Journal of Tuberculosis and Lung Disease, 27(5), 381-386.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
